User profiles for Maria Elena Flacco
Maria Elena FLACCOAssistant Professor, University of Ferrara Verified email at unife.it Cited by 6011 |
Risk of reinfection and disease after SARS‐CoV‐2 primary infection: meta‐analysis
ME Flacco, C Acuti Martellucci… - European journal of …, 2022 - Wiley Online Library
… Maria Elena Flacco and Cecilia Acuti Martellucci contributed equally to the present work. …
e A confirmed reinfection was defined as a new positive RT-PCR sample ≥ 45 days after a …
e A confirmed reinfection was defined as a new positive RT-PCR sample ≥ 45 days after a …
[HTML][HTML] Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor
Objectives To map the current status of head-to-head comparative randomized evidence
and to assess whether funding may impact on trial design and results. Study Design and …
and to assess whether funding may impact on trial design and results. Study Design and …
Phlebitis risk varies by peripheral venous catheter site and increases after 96 hours: a large multi‐centre prospective study
Aims This multi‐centre prospective field study evaluated whether peripheral venous catheter
site of insertion influences the risk of catheter‐related phlebitis. Potential predictors of …
site of insertion influences the risk of catheter‐related phlebitis. Potential predictors of …
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis
ME Flacco, CA Martellucci, F Bravi, G Parruti… - Heart, 2020 - heart.bmj.com
Objective It has been hypothesised that the use of ACE inhibitors and angiotensin receptor
blockers (ARBs) might either increase or reduce the risk of severe or lethal COVID-19. The …
blockers (ARBs) might either increase or reduce the risk of severe or lethal COVID-19. The …
[HTML][HTML] Risk of SARS-CoV-2 reinfection 18 months after primary infection: population-level observational study
ME Flacco, G Soldato, C Acuti Martellucci… - Frontiers in Public …, 2022 - frontiersin.org
Current data suggest that SARS-CoV-2 reinfections are rare. Uncertainties remain, however,
on the duration of the natural immunity, its protection against Omicron variant, and on the …
on the duration of the natural immunity, its protection against Omicron variant, and on the …
Nonobstructive versus obstructive coronary artery disease in acute coronary syndrome: a meta‐analysis
…, GM Costa, M Faustino, ME Flacco… - Journal of the …, 2016 - Am Heart Assoc
Background Differences in prognosis and baseline clinical presentation have been
documented among patient with acute coronary syndrome and coronary artery disease with …
documented among patient with acute coronary syndrome and coronary artery disease with …
Nursing students' knowledge and attitude on pressure ulcer prevention evidence-based guidelines: a multicenter cross-sectional study
V Simonetti, D Comparcini, ME Flacco… - Nurse education …, 2015 - Elsevier
Background Pressure ulcers still remain a significant problem in many healthcare settings.
Poor knowledge and negative attitudes toward pressure ulcer prevention could undesirably …
Poor knowledge and negative attitudes toward pressure ulcer prevention could undesirably …
SARS-CoV-2 pandemic: An overview
By the end of May 2020, SARS-CoV-2 pandemic caused more than 350,000 deaths
worldwide. In the first months, there have been uncertainties on almost any area: infection …
worldwide. In the first months, there have been uncertainties on almost any area: infection …
Efficacy of a nurse-led email reminder program for cardiovascular prevention risk reduction in hypertensive patients: A randomized controlled trial
…, M Di Nicola, LM Capasso, ME Flacco… - International journal of …, 2014 - Elsevier
Background Many strategies have been evaluated to improve the prevention and control of
cardiovascular (CVD) risk factors. Nursing telephonic and tele-counseling individualized …
cardiovascular (CVD) risk factors. Nursing telephonic and tele-counseling individualized …
[HTML][HTML] Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected …
Aims This retrospective case-control study was aimed at identifying potential independent
predictors of severe/lethal COVID-19, including the treatment with Angiotensin-Converting …
predictors of severe/lethal COVID-19, including the treatment with Angiotensin-Converting …